Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

Blue Rhino® G2-Multi Percutaneous Tracheostomy Introducer

Welcome History Benefits of PDT Products Tracheostomy Tubes Educational Resources



Revolutionizing percutaneous
tracheostomy for over 30 years

Surgical tracheostomies were performed as early as the 16th century in order to achieve adequate ventilation for patients who suffered from an obstruction of the upper airway or those who needed long-term ventilation.1

Concerned with the potential complications of surgical tracheostomies, Dr. Pasquale “Pat” Ciaglia revolutionized the procedure by partnering with Cook Medical to invent a minimally invasive percutaneous dilation technique. His original serial dilation set, introduced in 1987, evolved into the single dilator approach we know today: the Blue Rhino G2-Multi Percutaneous Tracheostomy Introducer.

Globally, percutaneous dilatational tracheostomy (PDT) has become one of the most commonly performed procedures in the intensive care unit (ICU).2 The single-dilation Ciaglia Blue Rhino technique has become many physicians’ preferred method when performing PDT.3, 4

Dr. Pasquale “Pat” Ciaglia
  1. Petros S. Percutaneous tracheostomy. Crit Care. 1999;3(2):R5–R10.
  2. Vargas M, Sutherasan Y, Antonelli M, et al. Tracheostomy procedures in the intensive care unit: an international survey. Crit Care. 2015;19(1):291.
  3. Newhouse E, Ondik MP, Carr M, et al. Who is performing percutaneous tracheotomies? Practice patterns of surgeons in the USA. Eur Arch Otorhinolaryngol. 2011;268(3):415–418.
  4. Cabrini L, Pintaudi M, Winterton D, et al. Choice of the appropriate tracheostomy technique. In: Servillo G, Pelosi P, eds. Percutaneous Tracheostomy in Critically Ill Patients. New York, NY: Springer; 2016:67–78.